The development of Hodgkin's disease and lymphoma during anticonvulsant therapy.
D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects*; D002648:Child; D004827:Epilepsy / Q000188:drug therapy; D004832:Epilepsy, Absence / Q000188:drug therapy; D004834:Epilepsy, Post-Traumatic / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D005260:Female; D006689:Hodgkin Disease / Q000209:etiology*; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D008223:Lymphoma / Q000209:etiology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000209:etiology*; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects
D000927:Anticonvulsants; D006827:Hydantoins; D010672:Phenytoin